ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CELC Celcuity Inc

16.30
0.00 (0.00%)
Pre Mercado
Última actualización: 03:16:42
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Celcuity Inc CELC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 16.30 03:16:42
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
16.30
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
04/4/202406:05GLOBECelcuity To Present at Upcoming Needham and Stifel Investor..
27/3/202415:01GLOBECelcuity Inc. Reports Fourth Quarter and Full Year 2023..
20/3/202406:05GLOBECelcuity Inc. Schedules Release of Fourth Quarter and Full..
06/3/202406:05GLOBECelcuity to Participate in Leerink Partners Global Biopharma..
28/2/202406:05GLOBECelcuity to Participate in Cowen’s 44th Annual Health Care..
23/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:05GLOBECelcuity Announces First Patient Dosed in Phase 1b/2..
20/2/202406:05GLOBECelcuity Appoints Eldon Mayer as Chief Commercial Officer
15/2/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202409:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202416:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/12/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202309:34EDGAR2Form 144 - Report of proposed sale of securities
06/12/202307:30GLOBECelcuity Presents Preclinical Data on Therapeutic Effects of..
05/12/202316:25EDGAR2Form 8-K - Current report
01/12/202310:02GLOBECelcuity to Present Preclinical Data for Gedatolisib at the..
30/11/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202315:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202307:15EDGAR2Form S-3/A - Registration statement under Securities Act of..
22/11/202307:05GLOBECelcuity to Participate in the 6th Annual Evercore ISI..
13/11/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202306:35EDGAR2Form 8-K - Current report
13/11/202306:05GLOBECelcuity Inc. Reports Third Quarter 2023 Financial Results..
06/11/202306:30GLOBECelcuity Inc. Schedules Release of Third Quarter 2023..
01/11/202306:05GLOBECelcuity To Present at Upcoming Stifel and Jefferies..
27/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202316:15EDGAR2Form 8-K - Current report
07/9/202315:05GLOBECelcuity to Host Virtual Science Day for Investors
01/9/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202309:58EDGAR2Form 144 - Report of proposed sale of securities
29/8/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202315:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202316:15EDGAR2Form 8-K - Current report
22/8/202315:05GLOBECelcuity Enters into a Clinical Trial Collaboration and..
22/8/202315:01GLOBECelcuity Announces Plan to Conduct Phase 1b/2 Clinical Trial..
11/8/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:10EDGAR2Form 8-K - Current report
10/8/202315:04GLOBECelcuity Inc. Reports Second Quarter 2023 Financial Results..
03/8/202306:30GLOBECelcuity Inc. Schedules Release of Second Quarter 2023..
31/7/202307:00GLOBECelcuity to Participate in the BTIG Virtual Biotechnology..

Su Consulta Reciente

Delayed Upgrade Clock